Abstract |
Two groups of four calves each were immunized either intramuscularly (i.m. vaccinated) or intranasally (i.n. vaccinated) at 2 and 6 weeks of age with ca. 10(9) CFU of a derivative of P. multocida serotype B:2 strain 85020 containing a deletion in the aroA gene (strain JRMT12). Both groups of calves and three unvaccinated control calves were challenged subcutaneously at 8 weeks of age with ca. 10(7) CFU of the wild-type 85020 strain. The first and second vaccinations caused a significant pyrexia and increase in the mean demeanor score (P <0.05) in i.m. but not i.n. vaccinated calves. Serum agglutinating activity against whole cells of P. multocida strain 85020 and immunoglobulin G antibody concentrations increased after the second vaccination in i.m. but not in i.n. vaccinated animals, and this difference was statistically significant (P <0.05). Concentrations of serum amyloid A (SAA) increased significantly 3 h after both the primary (P <0.05) and booster (P <0.001) i.m. vaccinations, but not in i.n. vaccinated calves. All four i.m. vaccinated calves were solidly immune to challenge with wild-type P. multocida B:2. However, the mean rectal temperatures, demeanor scores, and serum SAA concentrations of i.n. vaccinated and control calves increased significantly (P <0.01). Three i.n. vaccinated and two control calves were killed for humane reasons within 14 h postchallenge, and postmortem examination revealed pathological lesions consistent with hemorrhagic septicemia. These data showed that the aroA mutant strain, given i.m. as two doses 4 weeks apart, acted as an effective live- attenuated vaccine strain to protect calves against challenge with the virulent parent strain.
|
Authors | J Christopher Hodgson, Anna Finucane, Mark P Dagleish, Saeed Ataei, Roger Parton, John G Coote |
Journal | Infection and immunity
(Infect Immun)
Vol. 73
Issue 3
Pg. 1475-81
(Mar 2005)
ISSN: 0019-9567 [Print] United States |
PMID | 15731045
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Antibodies, Bacterial
- Bacterial Vaccines
- Serum Amyloid A Protein
- Vaccines, Attenuated
- Alkyl and Aryl Transferases
- 3-Phosphoshikimate 1-Carboxyvinyltransferase
|
Topics |
- 3-Phosphoshikimate 1-Carboxyvinyltransferase
- Administration, Intranasal
- Alkyl and Aryl Transferases
(genetics, immunology)
- Animals
- Antibodies, Bacterial
(blood)
- Bacterial Vaccines
(administration & dosage, immunology)
- Cattle
- Cattle Diseases
(mortality, prevention & control)
- Hemorrhagic Septicemia
(mortality, prevention & control, veterinary)
- Immunization Schedule
- Injections, Intramuscular
- Pasteurella Infections
(mortality, prevention & control, veterinary)
- Pasteurella multocida
(classification, genetics, immunology, pathogenicity)
- Serotyping
- Serum Amyloid A Protein
(analysis)
- Treatment Outcome
- Vaccination
(veterinary)
- Vaccines, Attenuated
(administration & dosage, immunology)
|